MedPath

Vaginal Elasticity Assessment Before and After Brachytherapy/Pelvic Radiation

Completed
Conditions
Radiation Injuries
Registration Number
NCT03667859
Lead Sponsor
Rambam Health Care Campus
Brief Summary

Female patients with either uterine/cervical malignancies will be evaluated for vaginal elasticity using vaginal tactile imaging both before and after radiation treatment.

Detailed Description

Patients will be recruited and sign a consent form. The patients included are patients with either uterine/cervical malignancies. Each participant undergoes radiation treatment either as primary or complementary treatment.

Assessment of vaginal elasticity via vaginal tactile imaging will be performed at 3 different points:

* Before the first treatment session (baseline).

* After the last session of laser treatment.

* 3 months post final treatment. Every patient will serve as her own control. Demographic, gynecologic and obstetric history will be obtained from patients' electronic files.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
25
Inclusion Criteria
  • Any woman undergoing either brachytherapy or pelvic radiation treatment as primary or complementary treatment for a cervical/uterine malignancy.
Exclusion Criteria
  • Women that are not in the age range.
  • Women with massive vaginal bleeding.
  • Women after pelvic exenteration.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Vaginal elasticity assessmentup to 6 months from enrollment

Vaginal elasticity as measured by the vaginal tactile imager.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Rambam health care campus

🇮🇱

Haifa, Israel

Rambam health care campus
🇮🇱Haifa, Israel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.